Alzheimer’s disease: Modeling current and potential targets
By the time we are 65, one in ten of us will have contracted Alzheimer’s disease. This rises to fifty ...
Following excellent progress in this drug discovery project that we announced in March, I am delighted that our unique software, virtual screening capabilities and highly experienced team have contributed to Parkinson’s UK securing further funding for the novel gene transcription modulators collaboration we are working on along with Selcia.
We look forward to continuing to deliver molecular modeling support for the next phase of this important project.